207 related articles for article (PubMed ID: 29186361)
41. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.
Go C; He W; Zhong L; Li P; Huang J; Brinkley BR; Wang XJ
Oncogene; 2000 Jul; 19(32):3623-31. PubMed ID: 10951568
[TBL] [Abstract][Full Text] [Related]
42. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
[TBL] [Abstract][Full Text] [Related]
43. Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy.
Stelkovics E; Korom I; Marczinovits I; Molnar J; Rasky K; Raso E; Ficsor L; Molnar B; Kopper L; Krenacs T
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):433-41. PubMed ID: 18633319
[TBL] [Abstract][Full Text] [Related]
44. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
45. Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.
Brennan-Crispi DM; Hossain C; Sahu J; Brady M; Riobo NA; Mahoney MG
Oncotarget; 2015 Apr; 6(11):8593-605. PubMed ID: 25871385
[TBL] [Abstract][Full Text] [Related]
46. TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.
Yamamoto H; Ryu J; Min E; Oi N; Bai R; Zykova TA; Yu DH; Moriyama K; Bode AM; Dong Z
J Invest Dermatol; 2017 Jun; 137(6):1322-1332. PubMed ID: 28131816
[TBL] [Abstract][Full Text] [Related]
47. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion.
Darwiche N; Ryscavage A; Perez-Lorenzo R; Wright L; Bae DS; Hennings H; Yuspa SH; Glick AB
Oncogene; 2007 Oct; 26(48):6885-95. PubMed ID: 17525749
[TBL] [Abstract][Full Text] [Related]
48. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment.
Demehri S; Turkoz A; Kopan R
Cancer Cell; 2009 Jul; 16(1):55-66. PubMed ID: 19573812
[TBL] [Abstract][Full Text] [Related]
49. TPL2 Is an Oncogenic Driver in Keratocanthoma and Squamous Cell Carcinoma.
Lee JH; Lee JH; Lee SH; Do SI; Cho SD; Forslund O; Inn KS; Lee JS; Deng FM; Melamed J; Jung JU; Jeong JH
Cancer Res; 2016 Nov; 76(22):6712-6722. PubMed ID: 27503930
[TBL] [Abstract][Full Text] [Related]
50. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.
Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP
Am J Pathol; 2003 Jun; 162(6):2029-39. PubMed ID: 12759258
[TBL] [Abstract][Full Text] [Related]
51. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.
Filipowicz E; Adegboyega P; Sanchez RL; Gatalica Z
Cancer; 2002 Feb; 94(3):814-9. PubMed ID: 11857317
[TBL] [Abstract][Full Text] [Related]
52. Cell Type-Specific p38δ Targeting Reveals a Context-, Stage-, and Sex-Dependent Regulation of Skin Carcinogenesis.
Kiss A; Koppel AC; Murphy E; Sall M; Barlas M; Kissling G; Efimova T
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934690
[TBL] [Abstract][Full Text] [Related]
53. From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers.
Voiculescu V; Calenic B; Ghita M; Lupu M; Caruntu A; Moraru L; Voiculescu S; Ion A; Greabu M; Ishkitiev N; Caruntu C
Dis Markers; 2016; 2016():4517492. PubMed ID: 27642215
[TBL] [Abstract][Full Text] [Related]
54. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions.
Beesetti S; Mavuluri J; Surabhi RP; Oberyszyn TM; Tober K; Pitani RS; Joseph LD; Venkatraman G; Rayala SK
Oncogene; 2017 Nov; 36(44):6154-6163. PubMed ID: 28692051
[TBL] [Abstract][Full Text] [Related]
56. Unexpected roles for pRb in mouse skin carcinogenesis.
Ruiz S; Santos M; Lara MF; Segrelles C; Ballestín C; Paramio JM
Cancer Res; 2005 Nov; 65(21):9678-86. PubMed ID: 16266987
[TBL] [Abstract][Full Text] [Related]
57. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
58. Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis.
He W; Cao T; Smith DA; Myers TE; Wang XJ
Oncogene; 2001 Jan; 20(4):471-83. PubMed ID: 11313978
[TBL] [Abstract][Full Text] [Related]
59. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.
Wang J; Zhang K; Grabowska D; Li A; Dong Y; Day R; Humphrey P; Lewis J; Kladney RD; Arbeit JM; Weber JD; Chung CH; Michel LS
Mol Cancer Res; 2011 Dec; 9(12):1686-95. PubMed ID: 21970857
[TBL] [Abstract][Full Text] [Related]
60. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin.
Lymboussaki A; Kaipainen A; Hatva E; Västrik I; Jeskanen L; Jalkanen M; Werner S; Stenbäck F; Alitalo R
Br J Cancer; 1996 Jun; 73(11):1347-55. PubMed ID: 8645578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
